semaglutide not cold when delivered Storage & Temperature: What You Need to Know Medical Weight Loss Education Materials

Effectiveness Semaglutide patients typically see about 15% reduction in body weight, while Tirzepatide patients in clinical studies have lost closer to 20% or more

Serious but Less Common Risks While most people tolerate Wegovy well, there are more serious potential risks that require immediate medical attention

In some of those cases, symptoms improved after stopping the medication

As a result, patients are encouraged to maintain open communication with their healthcare providers and regularly share all medications taken to avoid unwanted interactions

Certain conditions create a higher baseline susceptibility to palpitations that semaglutide can then aggravate

Summary: Tirzepatide is no longer in shortage , which means compounding pharmacies cannot create copies of it unless there is a specific medical need